Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1567 per ML under NDC 68180067801. Its NADAC has been published 454 times since Mar 14, 2018.

FDA first approved this application on Feb 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

Oseltamivir Phosphate
$0.1567per ML

Strength

6 mg/mL

NDC

68180067801

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208347

FDA Approved

2/20/2018

TE Code

AB

On Market Since

2/21/2018

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 454 times since Mar 14, 2018, and over the history we have for it it has declined 89.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1567 per ML
All-time high$1.5268 (Apr 11, 2018)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1711
52-week low$0.1496
Median price$0.3891
Average price$0.5226
Largest weekly change-56.9% (Sep 20, 2023)
Weeks tracked454
Tracking sinceMar 14, 2018

Price History

1W

+0.8%

1M

+4.7%

3M

+3.7%

6M

-0.5%

1Y

-8.4%

3Y

-38.9%

5Y

-71.3%

All

-89.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Lupin Pharmaceuticals Inc., is $0.1567 per ML (NDC 68180067801), effective Nov 18, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 89.7%. It has been tracked across 454 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Mar 14, 2018, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $1.5268 (Apr 11, 2018), with a median of $0.3891 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 68180067801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.